Inactivation of parvovirus B19 during pasteurization of human serum albumin.
about
Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.Parvovirus B19 - Revised.Human erythrovirus B19 and blood transfusion - an update.Ammonia disinfection of hatchery waste for elimination of single-stranded RNA viruses.The mantra of blood safety: time for a new tune?Composting for avian influenza virus elimination.Characterization of Markers of the Progression of Human Parvovirus B19 Infection in Virus DNA-Positive Plasma SamplesTransfusion and risk of infection in Canada: UPDATE 2004.Transfusion and risk of infection in Canada: Update 2005.Transfusion and risk of infection in Canada: Update 2006.Clinical aspects of parvovirus B19 infection.Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.Biosecurity aspects and pathogen inactivation in acidified high risk animal by-products.Pathogen safety of human C1 esterase inhibitor concentrate.Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration.Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies.Inactivation of Viruses and Bacteriophages as Models for Swine Hepatitis E Virus in Food Matrices.Virus inactivation and protein recovery in a novel ultraviolet-C reactor.Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non-leucoreduced platelet-rich plasma-derived platelets suspended in plasma.Studies on the inactivation of human parvovirus 4.Inactivation and neutralization of parvovirus B19 Genotype 3.Variability of parvovirus B19 genotype 2 in plasma products with different compositions in the inactivation sensitivity by liquid-heating.Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification.Variability of parvovirus B19 to inactivation by liquid heating in plasma products.Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products.Different susceptibility of B19 virus and mice minute virus to low pH treatment.Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the biological safety of heat treatment of manureRisk to public and/or animal health of the treatment of dead‐in‐shell chicks (Category 2 material) to be used as raw material for the production of biogas or compost with Category 3 approved methodEffective inactivation of a wide range of viruses by pasteurization.Parvovirus B19 transmission by a high-purity factor VIII concentrate.Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing.Improving Pasteurization to Preserve the Biological Components of Donated Human Milk
P2860
Q34124006-61F831E9-1163-46DD-B539-882C3A7E3B13Q34625443-BBE4A1A0-8C65-4042-B799-F6EF6F229A90Q34660084-3FAC41AD-51E4-4314-91DB-B5662691C2AEQ35091912-A8964694-29D5-4D1F-8294-C4BEAC5D4D23Q35675880-34835AB2-1B06-4127-B0B5-461B1E92F3C0Q35941159-FFF8AEE3-08FA-41EA-950F-821EF0FB9974Q36058219-C7DCE554-97E5-481A-B6A0-4FAC9663915BQ36170838-5CB9FF52-9AF0-4FC2-B7FF-244436EC0C55Q36171013-C1669A13-6FB4-4CEE-92B9-469A6AF9E316Q36171185-1A835982-4BAB-44C3-B8C8-22D667F8193CQ36589340-0E41076E-E221-46AC-AB53-1A992CE0BFD9Q38432271-20B89BD7-C596-43EB-842A-6C79037BDE4DQ39364143-7274E2FB-4A00-4143-8A55-C396C72F6BDFQ39380695-DB31FBF8-F386-4E71-93DC-9E02F6889A0CQ39992302-616D65D3-2DB7-419F-9AAC-A224AE6B3BB1Q40075393-351CED36-C306-4009-9AF9-7243B2871958Q40078515-78D8BFBC-3B47-414F-94C8-A5BE506E1292Q40338659-B695592C-1EF6-4180-A836-C360992275B6Q40413803-2CBDBC3B-4089-481D-9724-8D94A283D347Q40514517-CE68D701-BA9A-4907-ADFA-4A883E89E650Q40555863-03F2772F-C16F-42F1-BCB8-D8AC1BD2F348Q42220047-3B914EC9-9E53-4FA5-A52C-B22853AF3922Q42270009-5BD685B2-5BBB-4256-8808-6A706740A8A1Q44659453-50576CA0-89A8-493B-B4EE-957F2D2151E7Q44852251-84D88AE5-D3B5-4336-9228-022347B3FE1BQ44964053-4254DE68-486F-4650-A96B-64CC03A6362BQ45241512-CD46B782-2317-4819-B79D-E721F41ADED8Q45410532-FEA27C14-D9A7-4ADC-B94E-0F7FC232D272Q45620572-45166DB7-FF4B-4AE1-88B2-34A41490D7F8Q46500516-9D800D1D-7A5F-460A-B529-EBAA49F0E690Q47144016-ECEAF5DB-D569-49E3-A25B-585F9BFFC3D4Q47157460-0208E9F2-9597-47D5-BC10-DBBF461ADDB4Q47392893-C63D075A-2B4C-4DC4-82AA-2B9F66530851Q47786736-F8265E40-6788-40D0-92C8-2371DDFE729FQ53237311-ECF90C89-DB4A-410F-9567-BE1464FB9659Q57816928-60ADBE33-0FC8-49E8-AA0E-F9FC5C23E880
P2860
Inactivation of parvovirus B19 during pasteurization of human serum albumin.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Inactivation of parvovirus B19 during pasteurization of human serum albumin.
@en
Inactivation of parvovirus B19 during pasteurization of human serum albumin.
@nl
type
label
Inactivation of parvovirus B19 during pasteurization of human serum albumin.
@en
Inactivation of parvovirus B19 during pasteurization of human serum albumin.
@nl
prefLabel
Inactivation of parvovirus B19 during pasteurization of human serum albumin.
@en
Inactivation of parvovirus B19 during pasteurization of human serum albumin.
@nl
P2093
P2860
P1433
P1476
Inactivation of parvovirus B19 during pasteurization of human serum albumin.
@en
P2093
Hannelore Willkommen
Ivo Schmidt
Johannes Blümel
Johannes Löwer
P2860
P304
P356
10.1046/J.1537-2995.2002.00158.X
P577
2002-08-01T00:00:00Z